Studying the environment around cancer cells for more precise treatment

Through ten years as a Center for Excellence (CFE), CCBIO contributed to more precise treatments by researching the biological characteristics of cancer and the environment around cancer cells.

Et bilde av en kreftcelle, satt sammen med et bilde av Lars Akslen.

"The results from CCBIO range from basic biological discoveries to direct influence on clinical guidelines and national health policy. For example, findings on the spread of cancer cells in breast cancer patients have been incorporated into national guidelines for breast cancer treatment, and a new type of treatment for pancreatic cancer has resulted in significant improvements in survival."

Read the whole story here: https://www4.uib.no/forskning/aktuelt/studerer-miljoet-rundt-kreftcellene-for-mer-presis-behandling

Charalampos Tzoulis receives the Brain Council's Research Prize 2026

Charalampos Tzoulis, professor at the University of Bergen and senior consultant at the Department of Neurology, Haukeland University Hospital, has been awarded the Norwegian Brain Council's Research Prize 2026 for his outstanding research on Parkinson's disease and related brain diseases. 

Every year, the Norwegian Brain Council awards an award to a researcher who has made a significant contribution to brain research and increased awareness of brain diseases in Norway. This year, the award is given to Charalampos Tzoulis for his outstanding research efforts related to neurodegenerative brain diseases. Tzoulis' work has been important in increasing knowledge about the biological mechanisms behind Parkinson's disease and other neurodegenerative brain diseases. Tzoulis' research combines basic research, biomarker development and clinical studies to better understand the disease, develop new treatment methods for those affected, and ultimately know how these serious diseases can be prevented.

The government has decided on a concept for the UiBRealfaghøyden

The challenges Norway faces require an extraordinary investment in science and technology. The University of Bergen is pleased that the government is now behind the major construction project UiBRealfaghøyden.

UiB Realfaghøyden is Norway's most important investment in science and technology. The government has now made a concept choice, and supports UiB's recommended solution, which involves rehabilitating the Science Building and the Physics Building, in addition to constructing a relief building. 

Read more here: https://www4.uib.no/om-uib/aktuelt/regjeringen-har-besluttet-konsept-for-uib-realfaghoyden

Funds for participation in the November Conference 2026

Utlysning av midler for å delta på Novemberkonferansen 2026 – K2 Nytt

UiB is announcing funding for academic staff who wish to participate with contributions at the November Conference 2026 in Rio de Janeiro. The conference will be held in November and is an important meeting place for collaboration between business and academia in Brazil and Norway, with a particular focus on energy transition.

Researchers who participate with a prepared presentation on one or more program items can receive up to 15,000 NOK in travel support. Employees who will coordinate sessions will be given priority. Temporary employees must have at least 16 months left on their contract at the time of application. Costs beyond the support amount must be covered by their own unit or other funds.

The application should briefly describe why participation is desirable, how it can strengthen collaboration with Brazilian partners, and any contributions to planned sessions. Applications should be sent to rosa.nogueira@uib.no by April 7, 2026.

Read more here:

Announcement of funding to participate in the November Conference 2026Download

This week's editorial - Svein Skeie

At Stavanger University Hospital, we have divided ourselves into two, with the new SUS at Ullandhaug and the old one at Våland. The students must also divide themselves. The Vestlandslege students and the internship students under the old arrangement must both find time and their way in the system. There will be many logistical challenges in addition to the running-in of the new hospital.

Nevertheless, many colleagues manage to find some time for research and student assignments in addition to teaching and supervision. If we are to raise research even further, we must improve cooperation between Campus Stavanger and Campus Bergen. As an employee at UiB/Med Fak, you are therefore encouraged to contact your academic colleagues in Stavanger/Bergen, challenge joint applications, contribute to other people's applications and, not least, increase the quality so that we receive more grants for external funding. The potential can be great if we work more together.

If you don't know who to contact, ask me!

Have a nice weekend from Stavanger 😊

Svein

Dissertation – Sindre Grindheim – 08.04.26

FACULTY OF MEDICINE

UNIVERSITY OF BERGEN

PUBLIC DEFENCE – Ph.D. DEGREE

Sindre Grindheim

The candidate is affiliated with the Department of Clinical Science (Klinisk institutt 2).

Main supervisor: Associate Professor Elham Baghestan
Co-supervisor: Professor Jørg Kessler

Prøveforelesning: Onsdag 08. april 2026 kl. 10.15

Location: Auditorium, Glasblokkene – Block 8. Haukelandsbakken 1

Stated subject: Mode of birth and the pelvic floor- translating science into advocacy»

Disputas: Onsdag 08. april 2026 kl. 12.15

Location: Auditorium, Glasblokkene – Block 8. Haukelandsbakken 1

Avhandlingens tittel: “Safe passage: Maternal and neonatal outcomes following forceps- and vacuum-assisted vaginal deliveries”

1st opponent: Professor Ranee Thakar, St. George's University of London, UK

2nd opponent: Associate Professor Solveig Bjellmo, Norwegian University of Science and Technology

3rd member of the committee: Professor Nils-Halvdan Morken, University of Bergen

The defense will be led by Professor Anagha Joshi.

Open to all interested parties

Disputes - Isil Kucuka - 14.04.26

FACULTY OF MEDICINE

UNIVERSITY OF BERGEN

PUBLIC DEFENCE – Ph.D. DEGREE

Isil Kucuka

The candidate is affiliated with the Department of Clinical Science (Klinisk institutt 2).

Main supervisor: Researcher Berghite Oftedal
Co-supervisors: Professor Eystein Husebye and Professor Anagha Joshi

Trial lecture:Tuesday, April 14, 2026 at 10:15 am

Location: Auditorium, Glasblokkene, Haukelandsbakken 15

Given topic: "Immunotherapeutic strategies for targeting autoimmune diseases"

Debate: Tuesday 14 April 2026 at 12.15

Location: Auditorium, Glasblokkene, Haukelandsbakken 15

Thesis title: “Clinical and Immunological Characterization of APS-1 Over Time”

1st opponent: Associate Professor Mohammad Alimohammadi, Uppsala University, Sweden      

2nd opponent: Professor Marit Inngjerdingen, University of Oslo       

3rd member of the committee: Postdoc. Marta Kaminska, University of Bergen

The defense will be led by Professor Emeritus Roland Jonsson.

Open to all interested parties

The time is approaching for registration for the main holiday!

Registration of main holiday must be registered in the self-service portal by May 1. Remember that all holiday must be clarified with the nearest supervisor before applying for holiday in the self-service portal and entered in the comments field: "Holiday has been clarified with the nearest supervisor."

If this is not included, the vacation application will be returned.

Refers also to the Employee Handbook

Universitetet i Bergen :: Medarbeiderhåndbok :: ferie

(edit)